Company

Profound Medical Corp.

Headquarters: Mississauga, ON, Canada

Employees: 146

CEO: Dr. Arun Swarup Menawat MBA, Ph.D.

TSX: PRN -1.47%

Market Cap

C$290.5 Million

CAD as of July 1, 2024

US$211.5 Million

Market Cap History

Profound Medical Corp. market capitalization over time

Evolution of Profound Medical Corp. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Profound Medical Corp.

Detailed Description

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Profound Medical Corp. has the following listings and related stock indices.


Stock: TSX: PRN wb_incandescent

Stock: NASDAQ: PROF wb_incandescent

Details

Headquarters:

2400 Skymark Avenue

Unit no. 6

Mississauga, ON L4W 5K5

Canada

Phone: 647 476 1350

Fax: 647 847 3739